316 Phase I study of lurbinectedin (PM01183) in combination with cisplatin (C) with or without aprepitant (Ap) in patients (pts) with advanced solid tumors
Forster, M., Sessa, C., Von Moos, R., Brown, N., Metaxas, Y., Griguolo, G., Lardelli, P., Coronado, C., Juan, L., Fernandez-Teruel, C., Soto-Matos, A., Stathis, A.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)30181-2
Date:
September, 2015
File:
PDF, 60 KB
english, 2015